Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.12.1329

Study on the diagnostic utility of serum levels of insulin-like growth Factor-I and insulin-like growth factor binding protein-3 in growth hormone deficiency  

Ji, Geun Ha (Department of Pediatrics, College of Medicine, Inje University)
Lee, Jeong Nyeo (Department of Clinical Laboratory Medicine, College of Medicine, Inje University)
Chung, Woo Yeong (Department of Pediatrics, College of Medicine, Inje University)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.12, 2008 , pp. 1329-1335 More about this Journal
Abstract
Purpose : This study aimed to determine the best cutoff line for insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-3 to discriminate between growth hormone deficiency (GHD) patients and the control group. Methods : Two hundred thirty subjects with normal controls (129 boys and 101 girls, aged 7-15 years), 14 patients with complete GHD (12 boys and 2 girls), and 17 patients with partial GHD (9 boys and 8 girls) were studied. IGF-I serum concentrations were measured by radioimmunoassay (RI), and IGFBP-3 concentrations were measured by immunoradiometric assay (IRMA). Results : The receiver operating characteristic (ROC) plot analysis showed that the best IGF-I and IGFBP-3 cutoff line was at -1 standard deviation (SD). By comparing IGF-I serum levels of GHD children within 1 SD of normal control, we determined the sensitivity (S) (87.5-100%) and specificity (Sp) (80-84.6%) according to the age group. For IGFBP-3, we determined the following values: S (58.7-85.7%) and Sp (79.2-85.5%). Eleven of 14 patients with complete GHD (78.5%) and 16 of 17 patients with partial GHD (94.1%) had IGF-I concentrations equal to or below -1 SD of the control group mean. Ten of 12 complete GHD children (83.3%) and 13 of 17 partial GHD children (76.5%) had IGFBP-3 concentrations equal or below -1 SD of the control group mean. Conclusion : We conclude that the measurement of IGF-I and IGFBP-3 concentrations might provide essential supplementary data in the diagnostic evaluation of patients with GHD. Our results support the need to use cutoff lines based on below -1 SD of the control.
Keywords
Insulin-like growth factor-I; Insulin-like growth factor binding protein-3; Growth hormone deficiency;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fideleff HL, Bouquete HR, Saskyn N, Pagano SM, Holland M. Variability of growth hormone response to repeated stimulation tests in children of normal height. Medicina (B Aires) 1994;54:630-4
2 Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-40   DOI
3 Juul A. Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001;55 suppl 2:94-9   DOI   ScienceOn
4 Strasburger CJ, Bidlingmaier M, Wu Z, Morrison KM. Normal values of insulin-like growth factor I and their clinical utility in adults. Horm Res 2001;55 Suppl 2:S100-5   DOI   ScienceOn
5 Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study. J Clin Endocrinol Metab 1996;81:1927-32   DOI
6 Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-8   DOI
7 Park MS, Kim DH. Diagnostic value of insulin-like growth factor-I in short stature. Yonsei Med J 1989;30:367-75   DOI
8 Oh PS, Kim KJ, Yu YI, Shin JH. Relationship of insulin-like growth factor with pharmacologically stimulated growth hormone secretion in growth hormone deficient children. Korean J Pediatr 1995;38:1394-403
9 Son BH, Chung WY. Diagnostic significance of serum IGF-I level in growth hormone deficiency . J Korean Soc Pediatr Endocrinol 1998;3:13-22
10 Rosenfeld RG, Wilson DM, Lee PD, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J pediatr 1986;109:428-33   DOI
11 Ranke MB, Schweizer R, Elmlinger MW, Weber K, Binder G, Schwarze CP, et al.. Significance of basal IGF-1, IGFBP- 3 and IGFBP-2 measurements in the diagnostics of short stature in children. Horm Res 2000;54:60-8   DOI   ScienceOn
12 Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998;19:203-23   DOI   ScienceOn
13 Lee PD, Rosenfeld RG. Clinical utility of insulin-like growth factor assays. Pediatrician 1987:14:154-61
14 Boquete HR, Sobrado PG, Fideleff HL, Sequera AM, Giaccio AV, Suarez MG, et al. Evaluation of diagnostic accuracy of insulin-like growth factor(IGF)-I and IGF-binding protein- 3 in growth hormone-deficient children and adults using ROC plot analysis. J Clin Endocrinol Metab 2003;88:4702-8   DOI
15 Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, et al. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004;89:2271-4   DOI   ScienceOn
16 Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, et al. Comparison between insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) measurement in the diagnosis of growth hormone deficiency. Endocr J 1993;40:185-90   DOI   ScienceOn
17 Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85:3990-3   DOI
18 Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130:197-204   DOI   ScienceOn
19 Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996;98:2612-5   DOI   ScienceOn
20 Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993;77:1294-9   DOI
21 Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, et al. Inaccuracy of insulin like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab 2005;90:6028-34   DOI
22 Pozo J, Martos-Moreno GA, Barrios V, Argente J. The IGF system in childhood: physiology and clinical implications. J Endocrinol Invest 2005;28:38-42
23 Baxter RC. Circulating binding proteins for the insulinlike growth factors. Trends Endocrinol Metab 1993;4:91-6   DOI   ScienceOn
24 Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six tests for the diagonosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-79   DOI
25 Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997;82:531-5   DOI
26 Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2(IGFBP-2), IGFBP-3 and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993;77:1294-9   DOI
27 Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiro G, Vaccaro F, et al. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf) 1995;43:43-7